IVVD · Company research
Invivyd, Inc. Common Stock (IVVD): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Invivyd (IVVD) Slips 6.62% to $0.62 as Shares Press Lower Support - Value Stock Ideas - https://www.siam.in/ | Invivyd (IVVD) Slips 6.62% to $0.62 as Shares Press Lower Support - Value Stock Ideas https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Oct 16, 2026 | neutral | 0 | 0.6 |
| Six new hires receive options to buy 157,500 Invivyd shares - Stock Titan | Six new hires receive options to buy 157,500 Invivyd shares Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| Lobbying Update: $60,000 of INVIVYD INC. lobbying was just disclosed - Quiver Quantitative | Lobbying Update: $60,000 of INVIVYD INC. lobbying was just disclosed Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 1, 2026 | neutral | 0 | 0.6 |
| $IVVD stock is down 12% today. Here's what we see in our data. - Quiver Quantitative | $IVVD stock is down 12% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 29, 2026 | neutral | 0 | 0.6 |
| In a trial, 56.5% had an adverse event, injection reaction or allergy with Invivyd's COVID antibody, versus 91.4% with an mRNA vaccine. - Stock Titan | In a trial, 56.5% had an adverse event, injection reaction or allergy with Invivyd's COVID antibody, versus 91.4% with an mRNA vaccine. Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| $IVVD stock is down 8% today. Here's what we see in our data. - Quiver Quantitative | $IVVD stock is down 8% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 22, 2026 | neutral | 0 | 0.6 |
| Invivyd management will join two live webcast chats in September - Stock Titan | Invivyd management will join two live webcast chats in September Stock Titan | View source ↗ | Stock Titan | Sep 8, 2026 | neutral | 0 | 0.6 |
| Invivyd (IVVD) gives its new CEO rich equity and a potential 0.5%–1.5% payout on any sale worth at least $5B, as Phase 3 COVID antibody data near. - Stock Titan | Invivyd (IVVD) gives its new CEO rich equity and a potential 0.5%–1.5% payout on any sale worth at least $5B, as Phase 3 COVID antibody data near. Stock Titan | View source ↗ | Stock Titan | Sep 1, 2026 | neutral | 0 | 0.6 |
| Invivyd Stock (IVVD) Opinions on Upcoming Phase 3 Results - Quiver Quantitative | Invivyd Stock (IVVD) Opinions on Upcoming Phase 3 Results Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 19, 2026 | neutral | 0 | 0.6 |
| Invivyd (IVVD) Stock Price Rises as Losses and PEMGARDA Risks Persist - Simply Wall Street | Invivyd (IVVD) Stock Price Rises as Losses and PEMGARDA Risks Persist Simply Wall Street | View source ↗ | Simply Wall Street | Aug 15, 2026 | neutral | 0 | 0.6 |
| Invivyd, Inc. (IVVD) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance | Invivyd, Inc. (IVVD) Reports Q2 Loss, Lags Revenue Estimates Yahoo Finance | View source ↗ | Yahoo Finance | Aug 13, 2026 | neutral | 0 | 0.6 |
| IVVD Forecast — Price Target — Prediction for 2027 - TradingView | IVVD Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Invivyd (IVVD): 10 Best NASDAQ Stocks Under $5 to Buy Right Now - Yahoo Finance | Invivyd (IVVD): 10 Best NASDAQ Stocks Under $5 to Buy Right Now Yahoo Finance | View source ↗ | Yahoo Finance | May 17, 2026 | neutral | 0 | 0.6 |
| IVVD Stock Tanks 19% Today – But This Analyst Believes It Has A Potential Upside Of Over 730% - Stocktwits | IVVD Stock Tanks 19% Today – But This Analyst Believes It Has A Potential Upside Of Over 730% Stocktwits | View source ↗ | Stocktwits | May 14, 2026 | neutral | 0 | 0.6 |
| Invivyd (NASDAQ:IVVD) Q1 Miss Sends Shares Lower as PEMGARDA Revenue Falls Short and R&D Costs Surge - ChartMill | Invivyd (NASDAQ:IVVD) Q1 Miss Sends Shares Lower as PEMGARDA Revenue Falls Short and R&D Costs Surge ChartMill | View source ↗ | ChartMill | May 14, 2026 | neutral | 0 | 0.6 |
| IVVD Stock Price and Chart — NASDAQ:IVVD - TradingView | IVVD Stock Price and Chart — NASDAQ:IVVD TradingView | View source ↗ | TradingView | Jan 29, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.